GSK is GSK PLC (Healthcare). Trading at $51.38. Current dividend yield: 3.59%.
Dividend snapshot
| Annual dividend rate | $1.80 |
| Current yield | 3.59% |
| Payment frequency | Quarterly |
| Next ex-dividend date | May 15, 2026 |
| Most recent payment date | May 15, 2026 |
| Last payment amount | $0.4611 |
| 5-year dividend CAGR | -4.03% |
| 3-year dividend CAGR | -0.10% |
| Payout ratio | 47% |
| Market cap | $101.90B |
| Exchange | NYQ |
Recent dividend payments
| Date | Amount / share |
|---|---|
| 2026-05-15 | $0.4610 |
| 2026-02-20 | $0.4860 |
| 2025-11-14 | $0.4170 |
| 2025-08-15 | $0.4280 |
| 2025-05-16 | $0.4290 |
| 2025-02-21 | $0.4010 |
| 2024-11-15 | $0.3890 |
| 2024-08-16 | $0.3860 |
About GSK
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.
Track GSK in DiviDrip
Add GSK to your portfolio on DiviDrip to track every buy, DRIP reinvestment, and dividend payment in one place. Free, no credit card, no upsell — built by dividend investors, for dividend investors.
- Open DiviDrip — search GSK and add your shares.
- View the GSK Dividend Triangle — see Revenue × EPS × Dividend growth at a glance.
- Stock Screener — find more dividend payers like GSK.
- DiviDrip Learn — free guides on DRIP, dividend tiers, ETF comparisons.
Data refreshed 2026-05-23. Not investment advice. Yields and prices change continuously; always verify the latest numbers in the live app before buying.